The 20 Best Lymphofollicular Hyperplasia Doctors Near Me in Lutherville Timonium, MD

Dr. Lee is a specialist in Interventional Pulmonary and serves as the Wang Interventional Pulmonary Fellowship Director. His areas of clinical expertise include interventional pulmonology, pleural disease, minimal invasive diagnostics and lung cancer at Johns Hopkins. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management and difficulty airways. In addition, he specializes in the diagnosis and management of pleural diseases and symptom relief with minimally invasive procedures. He is a fellow of the American College of Chest Physicians and the Johns Hopkins Master of Education for Health Professionals. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Lung Nodules, Lymphofollicular Hyperplasia, Endoscopy, and Advanced Bronchoscopy. Dr. Lee is board certified in American Board Of Internal Medicine.

Dr. Yarmus is a Professor of Medicine and Oncology and the director of Interventional Pulmonology at the Johns Hopkins University School of Medicine as well as the Vice Chair of Medicine for Strategy and Finance. He is an expert in the minimally invasive diagnosis and treatment of lung cancer and he leads the Interventional Pulmonary research program at Johns Hopkins with research investigating innovative minimally invasive device development and early-stage bronchoscopic treatments. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management, pleural diseases and symptom relief with minimally invasive procedures such as indwelling pleural catheters and pleurodesis. Dr. Yarmus is a member of the Fleischner Society and a fellow of the American College of Chest Physicians and the American Thoracic Society. Dr. Yarmus is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Lung Nodules, Lymphofollicular Hyperplasia, Endoscopy, and Advanced Bronchoscopy.

Dr. Howard Steiner is an instructor of medicine at the Johns Hopkins School of Medicine. He has been practicing pulmonary and sleep consultative medicine since 1989. In his role as a diagnostician, he guides the evaluation and management of respiratory problems including infectious, malignant, allergic, autoimmune, and sleep-related disorders. He has been part-time faculty in the Johns Hopkins Pulmonary Division since 1991, is a Fellow in the American College of Chest Physicians, and mentors medical students, residents, and pulmonary fellows training at the Johns Hopkins Hospital. Contact for Research Inquiries 10755 Falls Road Pavilion I, Suite 200 Lutherville, MD 21093 Phone: (410) 583-7124 Selected Publications Lwebuga-Mukasa JS, Steiner H. Monoclonal antibody to rat lung Maclura Pomifera agglutinin (MPA) lectin binding glycoprotein localizes apically on rat and human type II pneumocytes and Clara cells. J Cell Biol 107:71a, 1989. Roberts PJ, McBean GJ, Steiner H, Kohler C, Schwarcz R. Lesioning Effects of Ibotenate in the immature rat brain and protection by 2-amino-7 phosphonoheptanoic acid. Soc Neurosci Abst 9:261, 1983. Steiner H, Ingbar DI. Mechanisms of lung injury and repair. In: Matthay RA, Matthay MA, Wiedemann HP eds. Annual Review of Pulmonary and Critical Care Medicine. Hanley & Belfus (Philadelphia, 1989), pp 205-223. Steiner H, Lwebuga-Mukasa JS. A549 cells display distinct functional and morphologic properties depending on their culture substratum. J Cell Biol 107:71a, 1989. Steiner H, Lwebuga-Mukasa JS. A549 cells produce a factor which is Mitogenic for human lung fibroblasts. Amer Rev Resp Dis 139:A492 1989. Steiner H, McBean GJ, Kohler C, Roberts PJ, Schwarcz R. Ibotenate Induced neuronal degeneration in immature rat brain. Brain Research 307:117-124, 1984. Dr. Steiner is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Bronchiectasis, Obstructive Sleep Apnea, Lung Metastases, and Interstitial Lung Disease. Dr. Steiner is board certified in American Board Of Internal Medicine.

Dr. Karthik Suresh is a pulmonary and critical care physician. His clinical interests include acute lung injury and critical care medicine. He also specializes in the diagnosis and management of immune-related lung injury, especially in the context of autoimmune conditions and chemotherapy/immunotherapy for cancer. Dr. Suresh is a member of the Hopkins immune-related adverse events (irAE) tox team. He also takes care of critically ill patients in the medical and oncology ICUs. He’s a firm faculty member for the Janeway Firm of the Osler Housestaff Medical Service and provides teaching to medical students, housestaff and fellows. Dr. Suresh is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Pneumonia, Interstitial Lung Disease, Acute Interstitial Pneumonia, and Pulmonary Hypertension. Dr. Suresh is board certified in American Board Of Internal Medicine.

Ankur Gupta is a Radiologist practicing medicine in Lutherville Timonium, Maryland. Dr. Gupta is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Lung Nodules, Visceromegaly, Chronic Cough, and Vertigo.

Deepa Masrani is a Radiologist practicing medicine in Lutherville Timonium, Maryland. Dr. Masrani is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Fibrocystic Breast Disease, Breast Infection, Breast Lump, and Giant Mammary Hamartoma.

Maitri Kalra is a Hematologist Oncology specialist and an Oncologist practicing medicine in Lutherville, Maryland. She has been practicing medicine for over 17 years. Dr. Kalra is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Kalra is board certified in American Board Of Internal Medicine.

Opeyemi Ibidapo is a Radiologist practicing medicine in Towson, Maryland. He has been practicing medicine for over 17 years. Dr. Ibidapo is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Breast Lump, Galactocoele, Pleural Effusion, and Pleurisy.

Matthew Woodford is an Intensive Care Medicine provider practicing medicine in Towson, Maryland. He has been practicing medicine for over 18 years. Dr. Woodford is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His clinical expertise encompasses Emphysema, Bullae, Pneumonia, and Acute Interstitial Pneumonia.

Stephanie Wappel is an Intensive Care Medicine provider practicing medicine in Towson, Maryland. Dr. Wappel is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Obstructive Sleep Apnea, Drowsiness, Excessive Daytime Sleepiness, and Restless Legs Syndrome.

Donald Slack is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Slack is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Pneumonia, Interstitial Lung Disease, Acute Interstitial Pneumonia, Thyroidectomy, and Advanced Bronchoscopy.

Samuel Minkove is a Pulmonary Medicine provider practicing medicine in Towson, Maryland. Dr. Minkove is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), COVID-19, Pneumonia, Lymphofollicular Hyperplasia, and Vagotomy.

Christine Argento is a Pulmonary Medicine provider practicing medicine in Baltimore, Maryland. Dr. Argento is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Pleural Effusion, Lymphofollicular Hyperplasia, Lung Nodules, Endoscopy, and Gastrostomy.

Dr. Mullen attended the University of Virginia, graduating in 1987 with a BA in Chemistry and Spanish. She then attended medical school at Columbia University College of Physicians and Surgeons, graduating in 1991. After an internship in Internal Medicine at the Hospital of the University of Pennsylvania, she returned to Columbia Presbyterian Medical Center (now New York Presbyterian Hospital) for her residency in Diagnostic Radiology. She served at Co-Chief Resident from 1995 to 1996. Dr. Mullen completed her fellowship in Cross-Sectional Imaging (Ultrasound, CT and MRI) at Johns Hopkins Hospital in 1997. Dr. Mullen worked in private practice for 5 years, gaining experience in general radiology, and developing interest and expertise in breast imaging, women's imaging, and body imaging. She joined Johns Hopkins Radiology in 2002, and has been based at Johns Hopkins Imaging at Green Spring. Dr. Mullen has expertise in screening and diagnostic mammography, breast ultrasound, breast MRI, and breast interventional procedures, as well as general ultrasound and bone densitometry. Dr. Mullen is interested in clinical breast imaging and resident and fellow education. She has been the Breast Imaging Fellowship Director since 2013. Dr. Mullen is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Fibrocystic Breast Disease, Lymphofollicular Hyperplasia, Osteopenia, and Melorheostosis with Osteopoikilosis. Dr. Mullen is board certified in American Board Of Radiology.

Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Isaac Yoon is a primary care provider, practicing in Family Medicine in Lutherville Timonium, Maryland. Dr. Yoon is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. He is also highly rated in 68 other conditions, according to our data. His clinical expertise encompasses Acute Cystitis, Bronchitis, Cellulitis, and H1N1 Influenza.

Syed Nasir is an Oncologist practicing medicine in Towson, Maryland. Dr. Nasir is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. He is also highly rated in 85 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Paget Disease of the Breast. Dr. Nasir is currently accepting new patients.

Dr. Tanguy Seiwert is an oncologist in Baltimore, caring for patients with head and neck cancer. He serves as the director of the Head and Neck Cancer Oncology Disease Program and the co-director of the Bloomberg~Kimmel Institute for Immunotherapy at the Head and Neck Cancer Program at the Johns Hopkins School of Medicine. Dr. Seiwert earned his M.D. at Johannes Gutenberg Universität in Mainz, Germany. He completed his residency at the Duke University School of Medicine and performed a fellowship in hematology/oncology at the University of Chicago Medicine Mitchell Hospital-Hyde Park. Dr. Seiwert joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Seiwert was director of the Head and Neck Cancer Program at the University of Chicago. Dr. Seiwert’s research interests include immunologic and genomic profiling. He has given numerous invited talks on head and neck cancer both nationally and internationally. Dr. Seiwert served as chief editor for Frontiers in Head and Neck Cancer and as an editorial board member for the Journal of Clinical Oncology and Oral Oncology. He is a reviewer for multiple medical journals, including Lancet Oncology, Annals of Oncology and Clinical Cancer Research. He has been recognized by the American Association for Clinical Oncology for multiple Merit Awards and a Young Investigator Award. He was a member of the NCI Head and Neck Cancer Steering Committee, and is a member of the American Association for Clinical Oncology, the Society for Immunotherapy of Cancer, and the European Society of Clinical Oncology. Dr. Seiwert is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Glioma, Laryngeal Cancer, Tongue Cancer, Oral Squamous Cell Carcinoma, and Gastrostomy. Dr. Seiwert is board certified in American Board Of Internal Medicine.

Dr. Zambidis is Associate Professor of Oncology and Pediatrics at the Johns Hopkins University School of Medicine, and a member of the Johns Hopkins Kimmel Cancer Center. Dr. Zambidis’ clinical expertise is in the treatment of disorders of the immune system, histiocytic disorders, hematologic malignancies, blood and bone marrow transplantation (BMT), and regenerative medicine. His research interest focuses on advancing our understanding of pluripotent stem cells– the ‘master’ stem cells that can generate any new cell or tissue that the body needs to repair itself. Dr. Zambidis earned his M.D./Ph.D. in the Medical Scientist Training Program at the University of Rochester, Rochester, N.Y. He completed his Pediatrics Residency in the Department of Pediatrics, Washington University, St. Louis, Missouri, and his clinical/research fellowships in Pediatric Hematology/Oncology at the Johns Hopkins Hospital and the National Cancer Institute at the NIH. Dr. Zambidis has been interested in the biology of stem cells since he came to Johns Hopkins, in 2001. As a Pediatric Hematology/Oncology fellow, he was one of the very first Hopkins investigators to work with human embryonic stem cells (hESCs), beginning shortly after they were made available to the biomedical research community, in 2002. Dr. Zambidis was awarded the first NIH K08 Clinician-Scientist Training Award specifically investigating the therapeutic potential of human pluripotent stem cells (2004). After joining the Hopkins faculty, in 2005, he developed an experimental model of the early formation process of human blood and blood vessels using human pluripotent stem cells. The Zambidis laboratory at the Johns Hopkins Institute for Cell Engineering focuses on understanding the developmental biology of human hemato-vascular and human pluripotent stem cells. More recently, his group completed studies on highly efficient methods for generating nonintegrated, human induced pluripotent stem cell (hiPSC) lines from myeloid progenitors. His group has developed novel hiPSC-based vascular therapies for retinopathies, and more recently derived a new class of human pluripotent stem cells in a naïve ground state with new functionalities with even greater potency and stronger regenerative capacities. As a BMT physician-scientist, his long-term goal is to use hESC, hiPSC, and related pluripotent stem cell technologies to not only treat severe degenerative diseases, but also to elucidate the biological nature of cancer and aging. Dr. Zambidis is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His clinical expertise encompasses Gaucher Disease, Reticulohistiocytoma, Rosai-Dorfman Disease, and Lymphofollicular Hyperplasia. Dr. Zambidis is board certified in American Board Of Pediatrics.

Dr. Emily Ambinder is an Assistant Professor and Division Chief of Breast Imaging in the Johns Hopkins Medicine Department of Radiology and Radiological Science. She specializes in all aspects of breast imaging including mammography, tomosynthesis, breast ultrasound, breast MRI, and image-guided breast procedures. Dr. Ambinder graduated from Emory College in 2008 with a degree in Chemistry and Mathematics. She then attended Emory School of Medicine, and spent an additional year completing a Master’s of Science in Clinical Research at Emory's Laney Graduate School. After a preliminary internal medicine internship at the Greater Baltimore Medical Center, she attended diagnostic radiology residency at Johns Hopkins. Dr. Ambinder graduated radiology residency in 2018. Following residency, she completed a year-long fellowship in Breast Imaging at Johns Hopkins. Dr. Ambinder's research focuses on improving breast cancer detection, with a focus on new technologies and public health. She joins the Johns Hopkins faculty in August 2019. Dr. Ambinder is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Fibrocystic Breast Disease, Lymphofollicular Hyperplasia, Fibroadenoma, and Breast Lump. Dr. Ambinder is board certified in American Board Of Radiology.